Gene · 7941
Papers4,339
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 4,339
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Transcriptomic and Lipidomic Mapping of Macrophages in the Hub of Chronic Beta-Adrenergic-Stimulation Unravels Hypertrophy-, Proliferation-, and Lipid Metabolism-Related Genes as Novel Potential Markers of Early Hypertrophy or Heart Failure. | Biomedicines | 2022 | 35203431 | PubTator, text mining | PubMed |
| A Review on Transcriptional Responses of Interactions between Insect Vectors and Plant Viruses. | Cells | 2022 | 35203347 | PubTator, text mining | PubMed |
| Early Investigational and Experimental Therapeutics for the Treatment of Hypertriglyceridemia. | J Cardiovasc Dev Dis | 2022 | 35200696 | PubTator, text mining | PubMed |
| Impact of myocardial reperfusion on human plasma lipidome. | iScience | 2022 | 35198888 | PubTator, text mining | PubMed |
| Elucidating the Role of Cardiac Biomarkers in COVID-19: A Narrative Evaluation with Clinical Standpoints and a Pragmatic Approach for Therapeutics. | Curr Cardiol Rev | 2022 | 35196971 | PubTator, text mining | PubMed |
| Nutrigenetics, omega-3 and plasma lipids/lipoproteins/apolipoproteins with evidence evaluation using the GRADE approach: a systematic review. | BMJ Open | 2022 | 35193914 | PubTator, text mining | PubMed |
Circulating Cystatin C Is an Independent Risk Marker for Cardiovascular Outcomes, Development of Renal Impairment, and Long-Term Mortality in Patients With Stable Coronary Heart Disease: The LIPID Study. | J Am Heart Assoc | 2022 | 35179040 | PubTator, text mining | PubMed |
| Racial Disparities and Cardiometabolic Risk: New Horizons of Intervention and Prevention. | Curr Diab Rep | 2022 | 35175453 | PubTator, text mining | PubMed |
| Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders. | Int J Mol Sci | 2022 | 35163141 | PubTator, text mining | PubMed |
| Lipoprotein(a), a Lethal Player in Calcific Aortic Valve Disease. | Front Cell Dev Biol | 2022 | 35155427 | PubTator, text mining | PubMed |
| Caloric restriction in humans reveals immunometabolic regulators of health span. | Science | 2022 | 35143297 | PubTator, text mining | PubMed |
| Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed? | Nat Rev Cardiol | 2022 | 35102320 | PubTator, text mining | PubMed |
| Characterizing cellular heterogeneity in fibrotic hypersensitivity pneumonitis by single-cell transcriptional analysis. | Cell Death Discov | 2022 | 35091537 | PubTator, text mining | PubMed |
| ATF6α promotes prostate cancer progression by enhancing PLA2G4A-mediated arachidonic acid metabolism and protecting tumor cells against ferroptosis. | Prostate | 2022 | 35089606 | PubTator, text mining | PubMed |
| Identification of candidate targets and mechanisms involved in miRNA regulation in multiple myeloma. | World J Surg Oncol | 2022 | 35081971 | PubTator, text mining | PubMed |
| Tandem mass tag-based serum proteomic profiling revealed diabetic foot ulcer pathogenesis and potential therapeutic targets. | Bioengineered | 2022 | 35068329 | PubTator, text mining | PubMed |
| Body Mass Index and Association With Cardiovascular Outcomes in Patients With Stable Coronary Heart Disease - A STABILITY Substudy. | J Am Heart Assoc | 2022 | 35060389 | PubTator, text mining | PubMed |
| The Action of Vitamin D in Adipose Tissue: Is There the Link between Vitamin D Deficiency and Adipose Tissue-Related Metabolic Disorders? | Int J Mol Sci | 2022 | 35055140 | PubTator, text mining | PubMed |
| Potential Biomarkers for Post-Stroke Cognitive Impairment: A Systematic Review and Meta-Analysis. | Int J Mol Sci | 2022 | 35054785 | PubTator, text mining | PubMed |
| New Candidates for Biomarkers and Drug Targets of Ischemic Stroke-A First Dynamic LC-MS Human Serum Proteomic Study. | J Clin Med | 2022 | 35054033 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7941/papers?page=46